Who owns the AVERITAS PHARMA trademark?

The AVERITAS PHARMA trademark is owned by Averitas Pharma, Inc..

What class is the AVERITAS PHARMA trademark registered in?

The AVERITAS PHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for AVERITAS PHARMA?

The USPTO serial number for AVERITAS PHARMA is 88976570.

What is the registration number for AVERITAS PHARMA?

AVERITAS PHARMA is registered under USPTO registration number 5998658.

AVE

USPTO Trademark Record

ABANDONED

AVERITAS PHARMA

SN 88976570·Reg 5998658·Filed Aug 24, 2018

Owner Averitas Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AVERITAS PHARMA (Serial No. 88976570), Registration No. 5998658, is a abandoned US trademark filed on Aug 24, 2018 by Averitas Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

AVERITAS PHARMA (Reg. #5998658) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 24, 2018

SERIAL

88976570

REG#

5998658

REGISTERED

Feb 25, 2020

Owner

Applicant

Averitas Pharma, Inc.

Entity

Corporation

State

Address

360 Mount Kemble Ave., Morristown, NJ, 07960

Country

Attorney

NamePaul C. Llewellyn

Law firm

PAUL C. LLEWELLYN ARNOLD & PORTER KAYE SCHOLER LLP

Docket

1101804.0002

Address

250 WEST 55TH STREET, NEW YORK, NY 10019-9710, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateAug 24, 2018

Serial Number88976570

Registration No.5998658

Registration DateFeb 25, 2020

Status DateSep 04, 2026

Published for OppositionApr 30, 2019

Mark TypeStandard characters

Attorney Docket1101804.0002

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Nov 27, 2018

First use in commerce: Mar 29, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

CANCELLED SEC. 8 (6-YR)

Sep 04, 2026

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 25, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 25, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 22, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 21, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

DIVISIONAL PROCESSING COMPLETE

Jan 14, 2020

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Jan 14, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 20, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 10, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

Dec 10, 2019

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

USE AMENDMENT FILED

Dec 05, 2019

USE AMENDMENT FILED

TEAS REQUEST TO DIVIDE RECEIVED

Dec 05, 2019

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Dec 05, 2019

DIVISIONAL REQUEST RECEIVED

TEAS STATEMENT OF USE RECEIVED

Dec 05, 2019

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 25, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 30, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 30, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 10, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 22, 2019

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 28, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 14, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 13, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 13, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

PRIORITY ACTION WRITTEN

Dec 13, 2018

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Dec 13, 2018

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Dec 13, 2018

NOTIFICATION OF PRIORITY ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 10, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 04, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 28, 2018

NEW APPLICATION ENTERED

AVERITAS PHARMA

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Averitas Pharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Paul C. Llewellyn

Resources

Company